Journal of Drug Targeting

eISSN: 1029-2330pISSN: 1061-186X

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Aims and Scope

Journal of Drug Targeting is a peer-reviewed medical journal published by Informa that covers research on all aspects of drug delivery and drug targeting for molecular and macromolecular drugs. The editor in chief is Saghir Akhtar (College of Medicine, Qatar University). Less

Key Metrics

CiteScore
8.8
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q1Pharmaceutical Science
SNIP
0.85
3
Time to Publish
time-to-publish View Chart
4  Mo

Journal Specifications

Overview
  • Publisher
    TAYLOR & FRANCIS LTD
  • Language
    English
  • Frequency
    Monthly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 28%
4-6 60%
7-9 10%
>9 2%

Topics Covered

Curcumin
Breast cancer
Osteoarthritis
Drug delivery
Nanocarriers
Immunotherapy
Doxorubicin
Oxidative stress
Notch signaling pathway
Reactive oxygen species
Autophagy
Glioma
Mycobacterium tuberculosis
Metformin
Antibiotic resistance
Polymeric nanoparticles
Alzheimer's disease
Resveratrol
Tumor microenvironment
Paclitaxel

Recently Published Papers

Year-wise Publication

FAQs

Since when has Journal of Drug Targeting been publishing? Faqs

The Journal of Drug Targeting has been publishing since 1993 till date.

How frequently is the Journal of Drug Targeting published? Faqs

Journal of Drug Targeting is published Monthly.

Who is the publisher of Journal of Drug Targeting? Faqs

The publisher of Journal of Drug Targeting is TAYLOR & FRANCIS LTD.

Where can I find a journal's aims and scope of Journal of Drug Targeting? Faqs

For the Journal of Drug Targeting's Aims and Scope, please refer to the section above on the page.

How can I view the journal metrics of Journal of Drug Targeting on editage? Faqs

For the Journal of Drug Targeting metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Journal of Drug Targeting? Faqs

The eISSN number is 1029-2330 and pISSN number is 1061-186X for Journal of Drug Targeting.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Curcumin, Breast cancer, Osteoarthritis, Drug delivery, Nanocarriers, Immunotherapy, Doxorubicin, Oxidative stress, Notch signaling pathway, Reactive oxygen species, Autophagy, Glioma, Mycobacterium tuberculosis, Metformin, Antibiotic resistance, Polymeric nanoparticles, Alzheimer's disease, Resveratrol, Tumor microenvironment, Paclitaxel.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.